Abstract A spectrophotometric method and two titrimetric methods for the determination of nordiazepam via its iodobismuthate complex are described. These methods depend on the reaction of nordiazepam with potassium bismuth iodide which give an orange precipitate. Determination of nordiazepam in the precipitated complex is done iodometrically using standard potassium iodate solution or complexometrically using standard EDTA solution and xylenol orange indicator. Alternatively, the complex is dissolved in ethanol and its absorbance is measured at 323 nm. The three methods were applied for the determination of reference samples of nordiazepam in the concentration range of 1-30 mg ml À1 (for the iodometric method) and of 5-30 mg ml
Introduction
Nordiazepam (N-desmethyldiazepam) is an example of benzodiazepine drugs which are used as anxiolytics, minor tranquillizers and psychotropic drugs (William, 1989) . The therapeutic interest in these compounds justifies research to establish analytical methods for their determination in pharmaceutical formulations (Schutz, 1984) .The wide use of this group of drugs make extensive literature on the analysis of these compounds. Several methods have been reported for the quantitative determination of nordiazepam and other benzodiazepines including spectrophotometry (Garcia et al., 1983; Tan et al., 1999; El Bardicy et al., 1993; Martinez and Gimenez, 1981; Randez et al., 1991) , fluorimetry (Manes and Yakatan, 1975) , colorimetry (Stevens, 1978; EL-Shabouri and Sidhom, 1985) , polarographic (Brooks and Silva, 1975) , titrimetric (Barbato et al., 1979) and chromatographic methods (Robert et al., 2008; Kauppila et al., 2007; Ngwa et al., 2007; Rosa and Sue, 2007; Laloup et al., 2007; Stephane et al., 2006; Aure´lie and Christian, 2004; Lambert et al., 1995; Azzam et al., 1998; Reubaet et al., 1998; Kintz et al., 1996; Estadien et al., 1989; Kudo et al., 1988; Nitzche et al., 1984; Sun, 1978; Schuetz and Schneider, 1985; Walles et al., 2004; Archonate et al., 1998; Atta et al., 1999; Mura et al., 1987; Sanchez et al., 1983 
Apparatus
UV-Vis Spectrophotometer, Shimadzu 1800.
Procedures

Spectrophotometric determination of nordiazepam via its iodobismuthate complex
Transfer aliquot portions (0.2-1.6 ml) of N-desmethyldiazepam reference sample solution (2 mg ml À1 ) to a series of 10 ml centrifuge tubes, add 1 ml potassium iodobismuthate solution (B.P 1988) and mix well.
Allow to stand at room temperature for 5 min then centrifuge the mixtures for 5 min and decant. Wash the precipitate three times each with 5 ml 0.1 N hydrochloric acid. Centrifuge and decant. Transfer the content of the centrifuge tube to a 10 ml measuring flask using three successive portions each of 2 ml ethyl alcohol and complete to volume with the same solvent. Measure the absorbance of the solutions at 323 nm against ethyl alcohol as a blank. The absorbances at 323 nm produced by 0.04-0.32 mg ml À1 of nordiazepam are plotted against the respective concentration.
Determination of the composition of nordiazepam iodobismuthate complex
The continuous variation method and the mole ratio method were applied to determine the composition of nordiazepam iodobismuthate complex.
4.1.1.1. Continuous variation method (Inczedy, 1976) . Procedure: Add 0, 0.1, 0.2, . . . and 1 ml of 10 À2 M nordiazepam solution in 0.1 N hydrochloric acid to 1, 0.9, 0.8, . . . and 0 ml of 10 À2 M iodobismuthate solution, respectively, to a series of 10 ml centrifuge tubes. Complete as under procedure A.
4.1.1.2. The mole -ratio method (Inczedy, 1976) . Procedure: Introduce 1 ml 10 À2 M potassium iodobismuthate solution to a series of 10 ml centrifuge tubes containing different volumes of 10 À2 M nordiazepam (0.2, 0.4, 0.6, . . ., 2.2 ml) complete as under procedure A.
Complexometric determination of nordiazepam via its iodobismuthate
Transfer aliquot portions (1-6 ml) of nordiazepam solution (5 mg ml À1 ) to a series of 10 ml centrifuge tubes, to each tube add 5 ml iodobismuthic acid solution and mix well.
Allow to stand at room temperature for 5 min and decant the supernatant liquid, wash the precipitate three times each with 5 ml 0.1 N HCl, followed by centrifugation for 5 min and decant.
Quantitatively transfer the contents of each centrifuge tube to a 250 ml separating funnel using about 2 ml nitric acid and 150 ml of water, add 20 ml chloroform to extract the liberated iodine. Transfer the chloroformic layer into a 250 ml separating funnel and wash it thoroughly with two portions each of 20 ml distilled water. Collect the aqueous washings and aqueous layer into a 250 ml conical flask. Adjust the acidity of the combined aqueous solution to pH 1-3 (using pH meter), add three drops xylenol orange indicator and titrate with 0.01 M EDTA till full yellow color.
Each 1 ml of 0.01 M EDTA is equivalent to 5.414 mg nordiazepam.
Iodometric determination of nordiazepam via its iodobismuthate complex
Quantitatively transfer the precipitate (prepared as detailed under procedure B using aliquot portions 0.2-6 ml of nordiazepam solution) from each centrifuge tube to a 250 ml glass stopper conical flask using 20 ml water and 40 ml concentrated hydrochloric acid. Shake well until the precipitate dissolve completely and titrate the solution with 0.005 M potassium iodate using chloroform as indicator. Each 1 ml of 0.005 M KIO 3 is equivalent to 1.353 mg nordiazepam.
Application of the proposed method to the determination of nordiazepam in madar tablets
Weigh and powder twenty tablets. Transfer a quantity of powder equivalent to 20 mg nordiazepam (for spectrophotometric method) or 50 mg nordiazepam (for titrimetric method) to a 10 ml volumetric flask add 4 ml 0.1 N hydrochloric acid and shake for 5 min. Dilute to volume with distilled water and filter. Nordiazepam was determined according the procedures described before under Procedure 4.1, 4.2 and 4.3.
Results and discussion
Nordiazepam bismuth iodide complex was prepared by reacting nordiazepam with potassium bismuth iodide in acid medium (0.1 N hydrochloric acid) which gives an orange precipitated complex.
Spectrophotometric determination of nordiazepam via its iodobismuthate complex is done by reacting the drug with potassium iodobismuthate reagent (B.P 1988) not iodobismuthic acid which gives no sharp absorption peak. The absorption spectrum of nordiazepam iodobismuthate complex in ethyl alcohol exhibits a maximum at 323 nm. The effect of time on the stability of the formed complex solution in ethanol was studied by monitoring periodically at one minute interval the absorbance of a solution of the complex in ethanol at 323 nm using ethanol as a blank.
The absorbances at 323 nm produced by 0.04-0.32 mg ml
À1
of nordiazepam are plotted against the respective concentrations. According to the results of the linearity, the corresponding regression equation is computed and found to be:
where Y is the absorbance of the complex at 323 nm. C is the concentration in mg. The continuous variation method and the mole ratio method were applied to determine the composition of nordiazepam iodobismuthate complex spectrophotometrically. The continuous variation method is applied to determine the ratio of nordiazepam-iodobismuthate in the complex as under (Procedure 4.1.1.1) The principle of the method is that the mole -ratio of the metal ion and ligand is varied between 0 and 1 at constant total concentration C = C L + C M and the absorbance of the solution of different composition is measured. The absorbances are then plotted against the mole fraction X L of the ligand. This method revealed a ratio of 2:1 under the described condition as shown in Fig. 1 .
The stoichiometry of the reaction of nordiazepam and iodobismuthate is also determined by the mole ratio method as under (Procedure 4.1.1.2). The principle of the method depends on preparing a series of solutions in which the concentration of one component (usually C M ) is kept constant and that of the other is varied.
The absorbances of the solution are measured at the suitable wavelength and then plotted against the ratio of the variable and constant concentration (C L /C M ). With the increase of mole ratio, the absorbance increases approximately linearly and then become constant.
The abscissa of the point of intersection of the two tangents give the number of ligands in the complex (the ligand concentration that was varied). This method revealed a ratio of 2:1 nordiazepam-iodobismuthate, as shown in Fig. 2 .
Adopting the proposed procedure to determine different amount of authentic samples of nordiazepam, the concentration were calculated from the computed regression equation (Table 1) , the results are shown in Table 2 .
According to the mole ratio, the equivalence factors were calculated and subsequently used for the calculation of nordiazepam concentration in the two titrimetric methods. The complexometric method involves titration of the dissolved complex (bismuth content) with standard EDTA using xylenol orange indicator. The acidity of the solution is adjusted at pH 1:3. Each 1 ml of 0.01 M EDTA is equivalent to 5.414 mg nordiazepam.
Using the proposed procedure to determine different amounts of authentic sample of nordiazepam (5-30 mg ml À1 ), the concentrations were calculated according to the equivalence factor giving a mean percentage of 99.71 ± 0.47 as shown in Table 2 .
Iodometric determination of nordiazepam in the precipitated complex involves titrating the dissolved complex (iodine content) with standard potassium iodate solution and chloroform indicator, as under Procedure 4.3.
According to the mole ratio of nordiazepam and iodobismuthate, the equivalence factor was calculated for the iodometric method and used for the calculation of nordiazepam concentration. Each 1 ml of 0.005 M KIO 3 solution is equivalent to 1.353 mg nordiazepam.
Using the proposed method to determine different amounts of authentic sample of nordiazepam (1-30 mg ml À1 ) the concentrations were calculated according to the equivalence factor giving a mean percentage recovery of 99.08 ± 1.37, as shown in Table 2 .
The proposed procedure was applied to the determination of nordiazepam in madar tablets. The results are given in Table 2 . To evaluate the accuracy of the procedure when applied to the pharmaceutical preparation control experiments were performed by adding known concentration of the authentic nordiazepam to a previously analyzed aliquots of the tablets powder and the accuracy of the recovery of the added nordiazepam is computed, as shown in Table 2 .
It is evident that the percentage recoveries of the added nordiazepam have almost the same accuracy as those obtained with the authentic nordiazepam. Statistical comparison between the results of the suggested methods and the reference method (El Bardicy et al., 1993) was carried out using (t) test and variance ratio (F), as shown in Table 3 . It is clear that the calculated (t) and (F) values are less than the corresponding theoretical values indicating that no significant differences between the methods with respect to both precision and accuracy. 
